Predictors of Anticoagulation Control on Warfarin Therapy
| Status: | Completed |
|---|---|
| Conditions: | Atrial Fibrillation, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 5/21/2016 |
| Start Date: | June 2009 |
| End Date: | August 2013 |
The goal of this research study is to develop better dosing of anticoagulation medication in
both Caucasian and African Americans through analysis of various genetic factors.
both Caucasian and African Americans through analysis of various genetic factors.
This is a prospective cohort study among adult patients requiring warfarin therapy. Patients
presenting for anticoagulation will be identified at the start of therapy and followed
throughout their course until they reach maintenance dose. We will then develop a dosing
equation for warfarin using patient, environmental and genetic factors.
presenting for anticoagulation will be identified at the start of therapy and followed
throughout their course until they reach maintenance dose. We will then develop a dosing
equation for warfarin using patient, environmental and genetic factors.
Inclusion Criteria:
- All Caucasians and African Americans who are new to warfarin therapy
Exclusion Criteria:
- Under 21 years of age
- Non caucasian
- Non african american
- Have an abnormal INR before warfarin or heparin therapy
- Unable to provide consent
We found this trial at
2
sites
Philadelphia, Pennsylvania 19104
Click here to add this to my saved trials
Click here to add this to my saved trials